John F. Beary III, MD
This content is PDF only. Please click on the PDF icon to access.
To the editors: It is unfortunate that the Editors of the Annals did not seek the views of the pharmaceutical industry for publication in the same issue as the study by Wilkes and colleagues on prescription drug advertisements (1). Although they are important, the views of Food and Drug Administration (FDA) Commissioner David Kessler and those of Drs. Robert and Suzanne Fletcher comprise only two thirds of the other side of this issue.
Advertising and promotion are important aspects of free market economies. After spending an average of $230 million and 10 years to introduce a new product, a company
Beary JF. Pharmaceutical Ads in Journals. Ann Intern Med. 1992;117:616–618. doi: 10.7326/0003-4819-117-7-616
Download citation file:
Published: Ann Intern Med. 1992;117(7):616-618.
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use